5-(1-METHYLIMIDAZOL-2-YL)THIOPHENE-2-CARBOXYLIC ACID
|
- $116.64 - $617
- Product name: 5-(1-METHYLIMIDAZOL-2-YL)THIOPHENE-2-CARBOXYLIC ACID
- CAS: 914637-30-2
- MF: C9H8N2O2S
- MW: 208.24
- EINECS:
- MDL Number:MFCD08056306
- Synonyms:5-(1-METHYLIMIDAZOL-2-YL)THIOPHENE-2-CARBOXYLIC ACID;2-Thiophenecarboxylic acid, 5-(1-methyl-1H-imidazol-2-yl)-
4 prices
Selected condition：
Brand
- Atlantic Research Chemicals
- Matrix Scientific
- SynQuest Laboratories
Package
- 1g
- 1gm:
- 250mgs:
- ManufacturerAtlantic Research Chemicals
- Product numberCA00312
- Product description5-(1-Methylimidazol-2-yl)thiophene-2-carboxylicAcid 95%
- Packaging1gm:
- Price$236.82
- Updated2021-12-16
- Buy
- ManufacturerAtlantic Research Chemicals
- Product numberCA00312
- Product description5-(1-Methylimidazol-2-yl)thiophene-2-carboxylicAcid 95%
- Packaging250mgs:
- Price$116.64
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number082509
- Product description5-(1-Methylimidazol-2-yl)thiophene-2-carboxylic Acid 97%
- Packaging1g
- Price$617
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8H21-1-19
- Product description5-(1-Methylimidazol-2-yl)thiophene-2-carboxylic acid 97%
- Packaging1g
- Price$424
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Atlantic Research Chemicals | CA00312 | 5-(1-Methylimidazol-2-yl)thiophene-2-carboxylicAcid 95% | 1gm: | $236.82 | 2021-12-16 | Buy |
| Atlantic Research Chemicals | CA00312 | 5-(1-Methylimidazol-2-yl)thiophene-2-carboxylicAcid 95% | 250mgs: | $116.64 | 2021-12-16 | Buy |
| Matrix Scientific | 082509 | 5-(1-Methylimidazol-2-yl)thiophene-2-carboxylic Acid 97% | 1g | $617 | 2021-12-16 | Buy |
| SynQuest Laboratories | 8H21-1-19 | 5-(1-Methylimidazol-2-yl)thiophene-2-carboxylic acid 97% | 1g | $424 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|